Flibanserin for premenopausal hypoactive sexual desire disorder: Pooled analysis of clinical trials

Flibanserin for premenopausal hypoactive sexual desire disorder: Pooled analysis of clinical trialsBackground: Flibanserin, a 5-hydroxytryptamine 5-HT 1A  agonist and 5-HT 2A  antagonist, is indicated for the treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. This post hoc analysis assessed pooled efficacy and safety data for flibanserin in premenopausal women with HSDD.…